Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nephritis”

975 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 975 results

Post-approval studies (Phase 4)Looking for participantsNCT07323524
What this trial is testing

Dapagliflozin in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Brigham and Women's Hospital 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT06656962
What this trial is testing

The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)

Who this might be right for
Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)
Renmin Hospital of Wuhan University 15
Not applicableWithdrawnNCT00908986
What this trial is testing

Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis

Who this might be right for
Lupus Nephritis
Northwell Health
Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Not applicableNot Yet RecruitingNCT07785739
What this trial is testing

Clinical Prediction Model for Disease Progression in Primary Membranous Nephropathy

Who this might be right for
Membranous NephropathyNephrotic SyndromeKidney Diseases
Assiut University 128
Early research (Phase 1)Study completedNCT02693366
What this trial is testing

Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisChronic Kidney Diseases
Universidade Federal do Rio de Janeiro 5
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Testing effectiveness (Phase 2)UnknownNCT06113900
What this trial is testing

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Who this might be right for
Lupus Nephritis
Ain Shams University 50
Early research (Phase 1)Study completedNCT00705367
What this trial is testing

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 13
Not applicableWithdrawnNCT04369495
What this trial is testing

BAFF Levels and Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Universidad de Antioquia
Testing effectiveness (Phase 2)Study completedNCT01610492
What this trial is testing

Belimumab in Idiopathic Membranous Glomerulonephropathy

Who this might be right for
Glomerulonephritis, Membranous
GlaxoSmithKline 14
Testing effectiveness (Phase 2)Ended earlyNCT01628900
What this trial is testing

Prospective Study in the Emergency

Who this might be right for
Pyelonephritis
Assistance Publique - Hôpitaux de Paris 23
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Post-approval studies (Phase 4)Looking for participantsNCT07404436
What this trial is testing

Rivaroxaban in Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Beijing Friendship Hospital 134
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Post-approval studies (Phase 4)Looking for participantsNCT06712407
What this trial is testing

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
Calliditas Therapeutics AB 60
Not applicableStudy completedNCT01156428
What this trial is testing

Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease

Who this might be right for
ProteinuriaKidney InjuryChronic Kidney Disease
The Rogosin Institute 119
Large-scale testing (Phase 3)UnknownNCT04892212
What this trial is testing

Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis

Who this might be right for
Lupus NephritisImmunosuppressionEffect of Drug
Peking Union Medical College Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT05288855
What this trial is testing

Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis

Who this might be right for
Adolescent Lupus NephritisPediatric Lupus Nephritis
Aurinia Pharmaceuticals Inc. 9
Next Page